Related Experiment Video
Updated: Feb 24, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Insulin Neuritis and Effect of Pregabalin
Yasser Aladdin1, Thomas Jeerakathil, Zaeem A Siddiqi
1Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Insulin neuritis (IN) is a painful neuropathy that can occur in diabetes patients starting insulin therapy. Early recognition and management, including pain control and pausing insulin, can lead to spontaneous resolution.
Area of Science:
- Endocrinology
- Neurology
- Metabolic Disorders
Background:
- Insulin neuritis (IN) is a rare, painful neuropathy associated with diabetes mellitus.
- It typically arises in patients with poorly controlled blood sugar initiating insulin therapy, causing rapid normalization of glucose levels.
- The exact cause of IN remains unclear, though it presents with severe burning pain, weight loss, and mood disturbances.
Observation:
- This report details two cases of patients experiencing acute, severe neuropathic pain following the commencement of insulin therapy for uncontrolled diabetes mellitus.
- Both patients exhibited classic clinical manifestations consistent with insulin neuritis.
Findings:
- Insulin neuritis presents as excruciating, generalized burning pain.
- The condition is characterized by significant weight loss and associated mood issues.
- Diagnosis is primarily clinical, based on patient history and symptoms.
Implications:
- Insulin neuritis is a self-limiting condition that typically resolves on its own.
- Prompt diagnosis and management, including pain management and temporary insulin cessation, are crucial.
- Most cases do not necessitate extensive diagnostic work-up and improve spontaneously.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Oral Hypoglycemic Agents: Glinides
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Dipeptidyl Peptidase 4 Inhibitors
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...